SlideShare a Scribd company logo
1 of 27
Microvascular rejection
in the absence of anti-HLA DSAs
Maarten Naesens, MD PhD
KU Leuven, Belgium
ISN webinar May 31st 2022
1991 1993 1995 1997 1999 2001 2003 2005 2007 2009 2011 2013 2015 2017 2019 2022
1. Tissue injury
2. Antibody interaction
3. Serological evidence
Microvascular inflammation
Microvascular inflammation
C4d deposition
C4d deposition
HLA-DSA
Not considered as sABMR or ABMR in any Banff update
n=3171
Banff’01 Banff’13 Banff’17
DSA+ C4d- MVI+
DSA- C4d- MVI+
DSA+/C4d+ v > 0
ABMR
n=199
sABMR
n=292
ABMR
n=237
No ABMR
n=254
DSA- C4d+ 1st/MVI+
DSA- C4d- MVI+
DSA+ C4d- 1st+
Isolated ptc
Callemeyn, al. Am J Transplant 2021.
ABMR
n=74
sABMR
n=238
No ABMR
n=179
N=935
No ABMRh (N=727; 78%)
ABMRh (N=208; 22%)
HLA-DSA positive ABMRh
(N=85; 41%)
HLA-DSA negative ABMRh
N=123 (59%)
We observed a very high percentage
of patients with ABMRh without HLA-DSA
Senev et al. Am J Transplant 2019
 .
 .
 Ba
Coemans et al. Transplant Int 2021
Absolute number of cases
B. Histological picture of antibody-mediated rejection
D. Transplant glomerulopathy N = 1000 transplants; 3594 posttransplant biopsies
There is a high number of cases with ABMR histology
without HLA-DSA
DSAneg ABMRh differs from DSApos ABMRh
(97% MVI)
HISTOLOGICAL PICTURE
OF ABMR
(Banff criteria 1 and 2)
N=208 patients
HLA-DSA positive
N=85
HLA-DSA negative
N=123
More
graft failure
(33%)
Less
graft failure
(15%)
Time after
transplantation
(< 1y)
Light
microscopic
appearance More
Repeated
(52%)
More
transient
(27% repeat)
More
C4d positivity
(55%)
Less
C4d positivity
(38%)
C4d
p<0.001
p<0.001
p<0.01
First clinical
presentation
Equal
Senev et al. Am J Transplant 2019
DSAnegABMRh
DSAposABMRh
Senev et al. Am J Transplant 2018
Outcome of HLA-DSA negative ABMRh is better than in
HLA-DSA positive ABMRh
Outcome of HLA-DSA negative ABMRh is better than in
HLA-DSA positive ABMRh
Bestard & Grinyo, Am J Transplant 2018 Koenig et al Nat Comm 2019
ABMRh -> transplant glomerulopathy: one entity!
Logit
(ABMR)
Time post-transplant
First occurrence cg
• Highly significant in entire cohort (HR 1.19, p<0.001)
• And even in the DSA negative group (HR 1.16, p<0.001)
 ABMRh/cg
‘Exposure to’ ABMRh
Joint
modeling
Coemans et al. Transplant Int., 2021
Association between time-dependent aABMRh, cg and aABMRh/cg and
death-censored graft failure
(N=837 HLA-DSA negative patients; 3140 biopsies)
Coemans et al. Transplant Int., 2021
Parameters in the survival sub-modela
# phenotype
occurrences
HR (95% CI) P-value
aABMRh 205 1.17 (0.97 – 1.43) 0.10
cg 79 1.25 (1.08 – 1.55) 0.004
aABMRh/cg 268 1.32 (1.07 – 1.61) 0.008
Halloran et al. Am J Transplant, May 2022
Association between molecular ABMR and death-censored graft failure
is independent of the HLA-DSA status
(N=268)
Callemeyn et al. J Am Soc Nephrol 2020
(N=224)
Callemeyn et al. Kidney Int 2022
The cellular infiltrates of
kidney transplant rejection
HLA antigen
mismatch
“Missing Self”
NK cells are kept in balance by inhibitory and activating receptors
KIR
Tumoral
NK cells activate by “absence of self” (missing self)
NK cells activate by “absence of self” (missing self)
The concept of missing self requires NK cell education
Callemeyn et al. J Am Soc Nephrol 2021
Missing self, direct NK cell activation and MicroVascular Inflammation
Koenig et al. Nature Commun 2019
A B
C
Missing self associates with microvascular inflammation (MVI)
“high” missing self
Callemeyn et al. J Am Soc Nephrol 2021
Missing self independently increases risk of MVI
Pretransplant HLA-DSA
Callemeyn et al. J Am Soc Nephrol 2021 Koenig et al. J Am Soc Nephrol 2021
Callemeyn et al. JASN 2021
Koenig et al. Nat Commun 2020
102/222 of MVI (46%) not yet explained
15/44 of MVI (34%) not yet explained
Not all MVI is explained by DSA or by missing self
There are many
pathways of
NK cell activation
Hamada et al. HLA 2021
Non-HLA Ab detection immunoassay (NHADIA)
to detect non-HLA DSA
Lamarthée et al JASN 2021
MICA is confirmed as minor histocompatilibty antigen
in kidney transplantation leading to anti-MICA DSA and microvascular rejection
Carapito et al Nat Med 2022
N=935
No ABMRh (N=727; 78%)
ABMRh (N=208; 22%)
HLA-DSA positive ABMRh
(N=85; 41%)
HLA-DSA negative ABMRh
N=123 (59%)
CONCLUSION:
DSA-negative Microvascular Rejection is common
and further research is needed
Senev et al. Am J Transplant 2019
Not considered as sABMR or ABMR in any Banff update
n=3171
Banff’01 Banff’13 Banff’17
DSA+ C4d- MVI+
DSA- C4d- MVI+
DSA+/C4d+ v > 0
ABMR
n=199
sABMR
n=292
ABMR
n=74
sABMR
n=238
No ABMR
n=179
ABMR
n=237
No ABMR
n=254
DSA- C4d+ 1st/MVI+
DSA- C4d- MVI+
DSA+ C4d- 1st+
Isolated ptc
Callemeyn, al. Am J Transplant 2021.
ABMR (HLA-DSApos)
MVR (HLA-DSAneg)
(MVI based on
restricted definition)
No ABMR (DSA+)
New proposal
Registration:
https://conference.cst-transplant.ca/
Thank you!

More Related Content

What's hot

Adjuvant therapy for Renal Cancer
Adjuvant therapy for Renal CancerAdjuvant therapy for Renal Cancer
Adjuvant therapy for Renal CancerMauricio Lema
 
Membranoproliferative GN - Road to Diagnosis & Management - What is the evide...
Membranoproliferative GN - Road to Diagnosis & Management - What is the evide...Membranoproliferative GN - Road to Diagnosis & Management - What is the evide...
Membranoproliferative GN - Road to Diagnosis & Management - What is the evide...NephroTube - Dr.Gawad
 
Antithymocyte globulin associated Hypersensitivity reaction
Antithymocyte globulin associated Hypersensitivity reactionAntithymocyte globulin associated Hypersensitivity reaction
Antithymocyte globulin associated Hypersensitivity reactionDr. MITESHKUMAR MAURYA
 
Acute promyelocytic leukemia
Acute promyelocytic leukemiaAcute promyelocytic leukemia
Acute promyelocytic leukemiaRanjita Pallavi
 
IgA NEPHROPATHY (CLOSING THE LOOP) - Dr. Gawad
IgA NEPHROPATHY (CLOSING THE LOOP)  - Dr. GawadIgA NEPHROPATHY (CLOSING THE LOOP)  - Dr. Gawad
IgA NEPHROPATHY (CLOSING THE LOOP) - Dr. GawadNephroTube - Dr.Gawad
 
Panel discussion hemat onco update (1)
Panel discussion hemat onco update (1)Panel discussion hemat onco update (1)
Panel discussion hemat onco update (1)madurai
 
Atypical Hemolytic uremic syndrome
Atypical Hemolytic uremic syndromeAtypical Hemolytic uremic syndrome
Atypical Hemolytic uremic syndromeDr Shami Bhagat
 
Acute promyelocytic leukemia NCCN LATEST 2014 Guidelines
Acute promyelocytic leukemia NCCN LATEST 2014 GuidelinesAcute promyelocytic leukemia NCCN LATEST 2014 Guidelines
Acute promyelocytic leukemia NCCN LATEST 2014 GuidelinesDr Sandeep Kumar
 
Genetic Markers in AML
Genetic Markers in AMLGenetic Markers in AML
Genetic Markers in AMLFerdie Fatiga
 
Hereditary and acquired thrombophilia in RIF & recurrent abortion
Hereditary and acquired thrombophilia in RIF & recurrent abortionHereditary and acquired thrombophilia in RIF & recurrent abortion
Hereditary and acquired thrombophilia in RIF & recurrent abortionAmir Abbas Hedayati Asl
 
ABO incompatible kidney transplantation review
ABO incompatible kidney transplantation reviewABO incompatible kidney transplantation review
ABO incompatible kidney transplantation reviewMaarten Naesens
 
Rhabdomyolysis - Form Pathogenesis to Bedside - Dr. Gawad
Rhabdomyolysis - Form Pathogenesis to Bedside - Dr. GawadRhabdomyolysis - Form Pathogenesis to Bedside - Dr. Gawad
Rhabdomyolysis - Form Pathogenesis to Bedside - Dr. GawadNephroTube - Dr.Gawad
 
Antibody mediated rejection in kidney transplantation
Antibody mediated rejection in kidney transplantationAntibody mediated rejection in kidney transplantation
Antibody mediated rejection in kidney transplantationimrana tanvir
 
Updates in management of membranous nephropathy - Dr. Mohammed Kamal Nassar
Updates in management of membranous nephropathy - Dr. Mohammed Kamal NassarUpdates in management of membranous nephropathy - Dr. Mohammed Kamal Nassar
Updates in management of membranous nephropathy - Dr. Mohammed Kamal NassarMNDU net
 
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. GawadIgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. GawadNephroTube - Dr.Gawad
 
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. GawadANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. GawadNephroTube - Dr.Gawad
 

What's hot (20)

Adjuvant therapy for Renal Cancer
Adjuvant therapy for Renal CancerAdjuvant therapy for Renal Cancer
Adjuvant therapy for Renal Cancer
 
Membranoproliferative GN - Road to Diagnosis & Management - What is the evide...
Membranoproliferative GN - Road to Diagnosis & Management - What is the evide...Membranoproliferative GN - Road to Diagnosis & Management - What is the evide...
Membranoproliferative GN - Road to Diagnosis & Management - What is the evide...
 
Antithymocyte globulin associated Hypersensitivity reaction
Antithymocyte globulin associated Hypersensitivity reactionAntithymocyte globulin associated Hypersensitivity reaction
Antithymocyte globulin associated Hypersensitivity reaction
 
Acute promyelocytic leukemia
Acute promyelocytic leukemiaAcute promyelocytic leukemia
Acute promyelocytic leukemia
 
IgA NEPHROPATHY (CLOSING THE LOOP) - Dr. Gawad
IgA NEPHROPATHY (CLOSING THE LOOP)  - Dr. GawadIgA NEPHROPATHY (CLOSING THE LOOP)  - Dr. Gawad
IgA NEPHROPATHY (CLOSING THE LOOP) - Dr. Gawad
 
Recent advances in leukemia (2019)
Recent advances in leukemia (2019)Recent advances in leukemia (2019)
Recent advances in leukemia (2019)
 
Panel discussion hemat onco update (1)
Panel discussion hemat onco update (1)Panel discussion hemat onco update (1)
Panel discussion hemat onco update (1)
 
Atypical Hemolytic uremic syndrome
Atypical Hemolytic uremic syndromeAtypical Hemolytic uremic syndrome
Atypical Hemolytic uremic syndrome
 
Acute promyelocytic leukemia NCCN LATEST 2014 Guidelines
Acute promyelocytic leukemia NCCN LATEST 2014 GuidelinesAcute promyelocytic leukemia NCCN LATEST 2014 Guidelines
Acute promyelocytic leukemia NCCN LATEST 2014 Guidelines
 
Genetic Markers in AML
Genetic Markers in AMLGenetic Markers in AML
Genetic Markers in AML
 
Hereditary and acquired thrombophilia in RIF & recurrent abortion
Hereditary and acquired thrombophilia in RIF & recurrent abortionHereditary and acquired thrombophilia in RIF & recurrent abortion
Hereditary and acquired thrombophilia in RIF & recurrent abortion
 
ABO incompatible kidney transplantation review
ABO incompatible kidney transplantation reviewABO incompatible kidney transplantation review
ABO incompatible kidney transplantation review
 
Rhabdomyolysis - Form Pathogenesis to Bedside - Dr. Gawad
Rhabdomyolysis - Form Pathogenesis to Bedside - Dr. GawadRhabdomyolysis - Form Pathogenesis to Bedside - Dr. Gawad
Rhabdomyolysis - Form Pathogenesis to Bedside - Dr. Gawad
 
History
History History
History
 
Antibody mediated rejection in kidney transplantation
Antibody mediated rejection in kidney transplantationAntibody mediated rejection in kidney transplantation
Antibody mediated rejection in kidney transplantation
 
Updates in management of membranous nephropathy - Dr. Mohammed Kamal Nassar
Updates in management of membranous nephropathy - Dr. Mohammed Kamal NassarUpdates in management of membranous nephropathy - Dr. Mohammed Kamal Nassar
Updates in management of membranous nephropathy - Dr. Mohammed Kamal Nassar
 
Atypical hus
Atypical hus   Atypical hus
Atypical hus
 
Tmz ppt
Tmz pptTmz ppt
Tmz ppt
 
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. GawadIgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
 
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. GawadANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
 

Similar to 2022-05-31 ISN Webinar DSA negative ABMR .pptx

Federico Garnier - France - Tuesday 29 - Hematopoietic Stem Cells
Federico Garnier  - France - Tuesday 29 - Hematopoietic Stem CellsFederico Garnier  - France - Tuesday 29 - Hematopoietic Stem Cells
Federico Garnier - France - Tuesday 29 - Hematopoietic Stem Cellsincucai_isodp
 
Fleekic 19 2019 sep sab handout
Fleekic 19 2019 sep sab handoutFleekic 19 2019 sep sab handout
Fleekic 19 2019 sep sab handoutYuichiroOba
 
Actualización de los nuevos anticoagulantes orales en base a datos en práctic...
Actualización de los nuevos anticoagulantes orales en base a datos en práctic...Actualización de los nuevos anticoagulantes orales en base a datos en práctic...
Actualización de los nuevos anticoagulantes orales en base a datos en práctic...Sociedad Española de Cardiología
 
Predictors of locoregional &amp; distant failure in p16
Predictors of locoregional &amp; distant failure in p16Predictors of locoregional &amp; distant failure in p16
Predictors of locoregional &amp; distant failure in p16Rajib Bhattacharjee
 
2014 08-25 molecular microscopy - pro - budapest ynp meeting short
2014 08-25 molecular microscopy - pro - budapest ynp meeting short2014 08-25 molecular microscopy - pro - budapest ynp meeting short
2014 08-25 molecular microscopy - pro - budapest ynp meeting shortMaarten Naesens
 
donor selection in Haplo Transplant
donor selection in Haplo Transplantdonor selection in Haplo Transplant
donor selection in Haplo Transplantspa718
 
Curso CMF USAL_mar2023.pdf.Mieloma multiple
Curso CMF USAL_mar2023.pdf.Mieloma multipleCurso CMF USAL_mar2023.pdf.Mieloma multiple
Curso CMF USAL_mar2023.pdf.Mieloma multiplegimeniux17
 
Dimitri Karmpaliotis - CTO PCI in Post-CABG Patients
Dimitri Karmpaliotis - CTO PCI in Post-CABG PatientsDimitri Karmpaliotis - CTO PCI in Post-CABG Patients
Dimitri Karmpaliotis - CTO PCI in Post-CABG PatientsEuro CTO Club
 
Biomarkers in Ovarian Cancer
Biomarkers in Ovarian CancerBiomarkers in Ovarian Cancer
Biomarkers in Ovarian CancerMauricio Lema
 
Chronic Graft versus Host Disease - risk factors, pattern and transplant outc...
Chronic Graft versus Host Disease - risk factors, pattern and transplant outc...Chronic Graft versus Host Disease - risk factors, pattern and transplant outc...
Chronic Graft versus Host Disease - risk factors, pattern and transplant outc...Alok Gupta
 
1091217-Thinking Twice for Diabetes:Cardio-Renal or Renal-Cardiac Benefits of...
1091217-Thinking Twice for Diabetes:Cardio-Renal or Renal-Cardiac Benefits of...1091217-Thinking Twice for Diabetes:Cardio-Renal or Renal-Cardiac Benefits of...
1091217-Thinking Twice for Diabetes:Cardio-Renal or Renal-Cardiac Benefits of...Ks doctor
 
Expert Guidance on Current Standards and New Directions in Newly Diagnosed Mu...
Expert Guidance on Current Standards and New Directions in Newly Diagnosed Mu...Expert Guidance on Current Standards and New Directions in Newly Diagnosed Mu...
Expert Guidance on Current Standards and New Directions in Newly Diagnosed Mu...i3 Health
 
Computerized scan findings and their correlation with outcome in patients wit...
Computerized scan findings and their correlation with outcome in patients wit...Computerized scan findings and their correlation with outcome in patients wit...
Computerized scan findings and their correlation with outcome in patients wit...Amit Agrawal
 
ESMO Oesophageal cancer webinar.pdf
ESMO Oesophageal cancer webinar.pdfESMO Oesophageal cancer webinar.pdf
ESMO Oesophageal cancer webinar.pdfFarah Fara
 
Donor Selection: Cord Blood. Prof Elizabeth J Shpall
Donor Selection: Cord Blood. Prof Elizabeth J ShpallDonor Selection: Cord Blood. Prof Elizabeth J Shpall
Donor Selection: Cord Blood. Prof Elizabeth J Shpallspa718
 
Coronary CTA: The test of choice for obstructive CAD.
Coronary CTA: The test of choice for obstructive CAD.Coronary CTA: The test of choice for obstructive CAD.
Coronary CTA: The test of choice for obstructive CAD.cardiositeindia
 

Similar to 2022-05-31 ISN Webinar DSA negative ABMR .pptx (20)

Federico Garnier - France - Tuesday 29 - Hematopoietic Stem Cells
Federico Garnier  - France - Tuesday 29 - Hematopoietic Stem CellsFederico Garnier  - France - Tuesday 29 - Hematopoietic Stem Cells
Federico Garnier - France - Tuesday 29 - Hematopoietic Stem Cells
 
Fleekic 19 2019 sep sab handout
Fleekic 19 2019 sep sab handoutFleekic 19 2019 sep sab handout
Fleekic 19 2019 sep sab handout
 
Actualización de los nuevos anticoagulantes orales en base a datos en práctic...
Actualización de los nuevos anticoagulantes orales en base a datos en práctic...Actualización de los nuevos anticoagulantes orales en base a datos en práctic...
Actualización de los nuevos anticoagulantes orales en base a datos en práctic...
 
Predictors of locoregional &amp; distant failure in p16
Predictors of locoregional &amp; distant failure in p16Predictors of locoregional &amp; distant failure in p16
Predictors of locoregional &amp; distant failure in p16
 
2014 08-25 molecular microscopy - pro - budapest ynp meeting short
2014 08-25 molecular microscopy - pro - budapest ynp meeting short2014 08-25 molecular microscopy - pro - budapest ynp meeting short
2014 08-25 molecular microscopy - pro - budapest ynp meeting short
 
donor selection in Haplo Transplant
donor selection in Haplo Transplantdonor selection in Haplo Transplant
donor selection in Haplo Transplant
 
Curso CMF USAL_mar2023.pdf.Mieloma multiple
Curso CMF USAL_mar2023.pdf.Mieloma multipleCurso CMF USAL_mar2023.pdf.Mieloma multiple
Curso CMF USAL_mar2023.pdf.Mieloma multiple
 
Dimitri Karmpaliotis - CTO PCI in Post-CABG Patients
Dimitri Karmpaliotis - CTO PCI in Post-CABG PatientsDimitri Karmpaliotis - CTO PCI in Post-CABG Patients
Dimitri Karmpaliotis - CTO PCI in Post-CABG Patients
 
Biomarkers in Ovarian Cancer
Biomarkers in Ovarian CancerBiomarkers in Ovarian Cancer
Biomarkers in Ovarian Cancer
 
mHSPC Feb 2023.pptx
mHSPC Feb 2023.pptxmHSPC Feb 2023.pptx
mHSPC Feb 2023.pptx
 
Chronic Graft versus Host Disease - risk factors, pattern and transplant outc...
Chronic Graft versus Host Disease - risk factors, pattern and transplant outc...Chronic Graft versus Host Disease - risk factors, pattern and transplant outc...
Chronic Graft versus Host Disease - risk factors, pattern and transplant outc...
 
1091217-Thinking Twice for Diabetes:Cardio-Renal or Renal-Cardiac Benefits of...
1091217-Thinking Twice for Diabetes:Cardio-Renal or Renal-Cardiac Benefits of...1091217-Thinking Twice for Diabetes:Cardio-Renal or Renal-Cardiac Benefits of...
1091217-Thinking Twice for Diabetes:Cardio-Renal or Renal-Cardiac Benefits of...
 
AML: improving standard therapy
AML: improving standard therapyAML: improving standard therapy
AML: improving standard therapy
 
Expert Guidance on Current Standards and New Directions in Newly Diagnosed Mu...
Expert Guidance on Current Standards and New Directions in Newly Diagnosed Mu...Expert Guidance on Current Standards and New Directions in Newly Diagnosed Mu...
Expert Guidance on Current Standards and New Directions in Newly Diagnosed Mu...
 
Computerized scan findings and their correlation with outcome in patients wit...
Computerized scan findings and their correlation with outcome in patients wit...Computerized scan findings and their correlation with outcome in patients wit...
Computerized scan findings and their correlation with outcome in patients wit...
 
PBoD CW.pdf
PBoD CW.pdfPBoD CW.pdf
PBoD CW.pdf
 
ESMO Oesophageal cancer webinar.pdf
ESMO Oesophageal cancer webinar.pdfESMO Oesophageal cancer webinar.pdf
ESMO Oesophageal cancer webinar.pdf
 
Donor Selection: Cord Blood. Prof Elizabeth J Shpall
Donor Selection: Cord Blood. Prof Elizabeth J ShpallDonor Selection: Cord Blood. Prof Elizabeth J Shpall
Donor Selection: Cord Blood. Prof Elizabeth J Shpall
 
20160218 hisham toma services
20160218 hisham toma services20160218 hisham toma services
20160218 hisham toma services
 
Coronary CTA: The test of choice for obstructive CAD.
Coronary CTA: The test of choice for obstructive CAD.Coronary CTA: The test of choice for obstructive CAD.
Coronary CTA: The test of choice for obstructive CAD.
 

More from Maarten Naesens

Calcineurin inhibitor nephrotoxicity - once and for all?
Calcineurin inhibitor nephrotoxicity - once and for all?Calcineurin inhibitor nephrotoxicity - once and for all?
Calcineurin inhibitor nephrotoxicity - once and for all?Maarten Naesens
 
The place of baseline biopsy histology
The place of baseline biopsy histology The place of baseline biopsy histology
The place of baseline biopsy histology Maarten Naesens
 
ESOT barcelona - histological endpoints in kidney transplantation ultrashort-2
ESOT barcelona - histological endpoints in kidney transplantation ultrashort-2ESOT barcelona - histological endpoints in kidney transplantation ultrashort-2
ESOT barcelona - histological endpoints in kidney transplantation ultrashort-2Maarten Naesens
 
Personalized Medicine for Kidney Transplantation
Personalized Medicine for Kidney TransplantationPersonalized Medicine for Kidney Transplantation
Personalized Medicine for Kidney TransplantationMaarten Naesens
 
Stockholm Karolinska meeting: Graft histology - a marker of pain and sufferin...
Stockholm Karolinska meeting: Graft histology - a marker of pain and sufferin...Stockholm Karolinska meeting: Graft histology - a marker of pain and sufferin...
Stockholm Karolinska meeting: Graft histology - a marker of pain and sufferin...Maarten Naesens
 
Banff 2017 meeting presentation - early versus late inflammation
Banff 2017 meeting presentation - early versus late inflammationBanff 2017 meeting presentation - early versus late inflammation
Banff 2017 meeting presentation - early versus late inflammationMaarten Naesens
 
HLA antistoffen en niertransplantatie
HLA antistoffen en niertransplantatieHLA antistoffen en niertransplantatie
HLA antistoffen en niertransplantatieMaarten Naesens
 
Niertransplantatie voor dummies - Renal Transplantation for Dummies
Niertransplantatie voor dummies - Renal Transplantation for DummiesNiertransplantatie voor dummies - Renal Transplantation for Dummies
Niertransplantatie voor dummies - Renal Transplantation for DummiesMaarten Naesens
 
Transplantation 2020 - the big picture
Transplantation 2020 - the big pictureTransplantation 2020 - the big picture
Transplantation 2020 - the big pictureMaarten Naesens
 
Emerging factors predicting outcome after kidney transplantation
Emerging factors predicting outcome after kidney transplantationEmerging factors predicting outcome after kidney transplantation
Emerging factors predicting outcome after kidney transplantationMaarten Naesens
 
April 2015 - Maarten Naesens - Early renal biopsies- impact of chronic lesion...
April 2015 - Maarten Naesens - Early renal biopsies- impact of chronic lesion...April 2015 - Maarten Naesens - Early renal biopsies- impact of chronic lesion...
April 2015 - Maarten Naesens - Early renal biopsies- impact of chronic lesion...Maarten Naesens
 
Renal failure after non-renal transplantation
Renal failure after non-renal transplantationRenal failure after non-renal transplantation
Renal failure after non-renal transplantationMaarten Naesens
 
ABO incompatible living donor kidney transplantation - REVIEW in living donor...
ABO incompatible living donor kidney transplantation - REVIEW in living donor...ABO incompatible living donor kidney transplantation - REVIEW in living donor...
ABO incompatible living donor kidney transplantation - REVIEW in living donor...Maarten Naesens
 
2014 06-05 Pretransplant Evaluation for Kidney Transplantation - Pretransplan...
2014 06-05 Pretransplant Evaluation for Kidney Transplantation - Pretransplan...2014 06-05 Pretransplant Evaluation for Kidney Transplantation - Pretransplan...
2014 06-05 Pretransplant Evaluation for Kidney Transplantation - Pretransplan...Maarten Naesens
 
Talk on Kidney Transplant Fibrosis by Maarten Naesens
Talk on Kidney Transplant Fibrosis by Maarten NaesensTalk on Kidney Transplant Fibrosis by Maarten Naesens
Talk on Kidney Transplant Fibrosis by Maarten NaesensMaarten Naesens
 
Personalized Medicine in Transplantation by Maarten Naesens - at Université L...
Personalized Medicine in Transplantation by Maarten Naesens - at Université L...Personalized Medicine in Transplantation by Maarten Naesens - at Université L...
Personalized Medicine in Transplantation by Maarten Naesens - at Université L...Maarten Naesens
 
2014 01-24 eurotransplant meeting: resistive index after kidney transplantation
2014 01-24 eurotransplant meeting: resistive index after kidney transplantation2014 01-24 eurotransplant meeting: resistive index after kidney transplantation
2014 01-24 eurotransplant meeting: resistive index after kidney transplantationMaarten Naesens
 
2013 11-16 immuunsuppressie na orgaantransplantatie - probleem voor de nieren
2013 11-16 immuunsuppressie na orgaantransplantatie - probleem voor de nieren2013 11-16 immuunsuppressie na orgaantransplantatie - probleem voor de nieren
2013 11-16 immuunsuppressie na orgaantransplantatie - probleem voor de nierenMaarten Naesens
 
2013 09 omics in transplantation symposium leuven
2013 09 omics in transplantation symposium leuven2013 09 omics in transplantation symposium leuven
2013 09 omics in transplantation symposium leuvenMaarten Naesens
 

More from Maarten Naesens (20)

Calcineurin inhibitor nephrotoxicity - once and for all?
Calcineurin inhibitor nephrotoxicity - once and for all?Calcineurin inhibitor nephrotoxicity - once and for all?
Calcineurin inhibitor nephrotoxicity - once and for all?
 
The place of baseline biopsy histology
The place of baseline biopsy histology The place of baseline biopsy histology
The place of baseline biopsy histology
 
ESOT barcelona - histological endpoints in kidney transplantation ultrashort-2
ESOT barcelona - histological endpoints in kidney transplantation ultrashort-2ESOT barcelona - histological endpoints in kidney transplantation ultrashort-2
ESOT barcelona - histological endpoints in kidney transplantation ultrashort-2
 
Personalized Medicine for Kidney Transplantation
Personalized Medicine for Kidney TransplantationPersonalized Medicine for Kidney Transplantation
Personalized Medicine for Kidney Transplantation
 
Stockholm Karolinska meeting: Graft histology - a marker of pain and sufferin...
Stockholm Karolinska meeting: Graft histology - a marker of pain and sufferin...Stockholm Karolinska meeting: Graft histology - a marker of pain and sufferin...
Stockholm Karolinska meeting: Graft histology - a marker of pain and sufferin...
 
Banff 2017 meeting presentation - early versus late inflammation
Banff 2017 meeting presentation - early versus late inflammationBanff 2017 meeting presentation - early versus late inflammation
Banff 2017 meeting presentation - early versus late inflammation
 
HLA antistoffen en niertransplantatie
HLA antistoffen en niertransplantatieHLA antistoffen en niertransplantatie
HLA antistoffen en niertransplantatie
 
Niertransplantatie voor dummies - Renal Transplantation for Dummies
Niertransplantatie voor dummies - Renal Transplantation for DummiesNiertransplantatie voor dummies - Renal Transplantation for Dummies
Niertransplantatie voor dummies - Renal Transplantation for Dummies
 
BEYOND BELATACEPT
BEYOND BELATACEPT BEYOND BELATACEPT
BEYOND BELATACEPT
 
Transplantation 2020 - the big picture
Transplantation 2020 - the big pictureTransplantation 2020 - the big picture
Transplantation 2020 - the big picture
 
Emerging factors predicting outcome after kidney transplantation
Emerging factors predicting outcome after kidney transplantationEmerging factors predicting outcome after kidney transplantation
Emerging factors predicting outcome after kidney transplantation
 
April 2015 - Maarten Naesens - Early renal biopsies- impact of chronic lesion...
April 2015 - Maarten Naesens - Early renal biopsies- impact of chronic lesion...April 2015 - Maarten Naesens - Early renal biopsies- impact of chronic lesion...
April 2015 - Maarten Naesens - Early renal biopsies- impact of chronic lesion...
 
Renal failure after non-renal transplantation
Renal failure after non-renal transplantationRenal failure after non-renal transplantation
Renal failure after non-renal transplantation
 
ABO incompatible living donor kidney transplantation - REVIEW in living donor...
ABO incompatible living donor kidney transplantation - REVIEW in living donor...ABO incompatible living donor kidney transplantation - REVIEW in living donor...
ABO incompatible living donor kidney transplantation - REVIEW in living donor...
 
2014 06-05 Pretransplant Evaluation for Kidney Transplantation - Pretransplan...
2014 06-05 Pretransplant Evaluation for Kidney Transplantation - Pretransplan...2014 06-05 Pretransplant Evaluation for Kidney Transplantation - Pretransplan...
2014 06-05 Pretransplant Evaluation for Kidney Transplantation - Pretransplan...
 
Talk on Kidney Transplant Fibrosis by Maarten Naesens
Talk on Kidney Transplant Fibrosis by Maarten NaesensTalk on Kidney Transplant Fibrosis by Maarten Naesens
Talk on Kidney Transplant Fibrosis by Maarten Naesens
 
Personalized Medicine in Transplantation by Maarten Naesens - at Université L...
Personalized Medicine in Transplantation by Maarten Naesens - at Université L...Personalized Medicine in Transplantation by Maarten Naesens - at Université L...
Personalized Medicine in Transplantation by Maarten Naesens - at Université L...
 
2014 01-24 eurotransplant meeting: resistive index after kidney transplantation
2014 01-24 eurotransplant meeting: resistive index after kidney transplantation2014 01-24 eurotransplant meeting: resistive index after kidney transplantation
2014 01-24 eurotransplant meeting: resistive index after kidney transplantation
 
2013 11-16 immuunsuppressie na orgaantransplantatie - probleem voor de nieren
2013 11-16 immuunsuppressie na orgaantransplantatie - probleem voor de nieren2013 11-16 immuunsuppressie na orgaantransplantatie - probleem voor de nieren
2013 11-16 immuunsuppressie na orgaantransplantatie - probleem voor de nieren
 
2013 09 omics in transplantation symposium leuven
2013 09 omics in transplantation symposium leuven2013 09 omics in transplantation symposium leuven
2013 09 omics in transplantation symposium leuven
 

Recently uploaded

VIP Call Girls Noida Jhanvi 9711199171 Best VIP Call Girls Near Me
VIP Call Girls Noida Jhanvi 9711199171 Best VIP Call Girls Near MeVIP Call Girls Noida Jhanvi 9711199171 Best VIP Call Girls Near Me
VIP Call Girls Noida Jhanvi 9711199171 Best VIP Call Girls Near Memriyagarg453
 
Call Girls Service Chandigarh Gori WhatsApp ❤7710465962 VIP Call Girls Chandi...
Call Girls Service Chandigarh Gori WhatsApp ❤7710465962 VIP Call Girls Chandi...Call Girls Service Chandigarh Gori WhatsApp ❤7710465962 VIP Call Girls Chandi...
Call Girls Service Chandigarh Gori WhatsApp ❤7710465962 VIP Call Girls Chandi...Niamh verma
 
Call Girls in Mohali Surbhi ❤️🍑 9907093804 👄🫦 Independent Escort Service Mohali
Call Girls in Mohali Surbhi ❤️🍑 9907093804 👄🫦 Independent Escort Service MohaliCall Girls in Mohali Surbhi ❤️🍑 9907093804 👄🫦 Independent Escort Service Mohali
Call Girls in Mohali Surbhi ❤️🍑 9907093804 👄🫦 Independent Escort Service MohaliHigh Profile Call Girls Chandigarh Aarushi
 
Call Girls Service Chandigarh Grishma ❤️🍑 9907093804 👄🫦 Independent Escort Se...
Call Girls Service Chandigarh Grishma ❤️🍑 9907093804 👄🫦 Independent Escort Se...Call Girls Service Chandigarh Grishma ❤️🍑 9907093804 👄🫦 Independent Escort Se...
Call Girls Service Chandigarh Grishma ❤️🍑 9907093804 👄🫦 Independent Escort Se...High Profile Call Girls Chandigarh Aarushi
 
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Russian Escorts Aishbagh Road * 9548273370 Naughty Call Girls Service in Lucknow
Russian Escorts Aishbagh Road * 9548273370 Naughty Call Girls Service in LucknowRussian Escorts Aishbagh Road * 9548273370 Naughty Call Girls Service in Lucknow
Russian Escorts Aishbagh Road * 9548273370 Naughty Call Girls Service in Lucknowgragteena
 
pOOJA sexy Call Girls In Sector 49,9999965857 Young Female Escorts Service In...
pOOJA sexy Call Girls In Sector 49,9999965857 Young Female Escorts Service In...pOOJA sexy Call Girls In Sector 49,9999965857 Young Female Escorts Service In...
pOOJA sexy Call Girls In Sector 49,9999965857 Young Female Escorts Service In...Call Girls Noida
 
Leading transformational change: inner and outer skills
Leading transformational change: inner and outer skillsLeading transformational change: inner and outer skills
Leading transformational change: inner and outer skillsHelenBevan4
 
Udaipur Call Girls 📲 9999965857 Call Girl in Udaipur
Udaipur Call Girls 📲 9999965857 Call Girl in UdaipurUdaipur Call Girls 📲 9999965857 Call Girl in Udaipur
Udaipur Call Girls 📲 9999965857 Call Girl in Udaipurseemahedar019
 
VIP Call Girl Sector 88 Gurgaon Delhi Just Call Me 9899900591
VIP Call Girl Sector 88 Gurgaon Delhi Just Call Me 9899900591VIP Call Girl Sector 88 Gurgaon Delhi Just Call Me 9899900591
VIP Call Girl Sector 88 Gurgaon Delhi Just Call Me 9899900591adityaroy0215
 
💚😋Kolkata Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Kolkata Escort Service Call Girls, ₹5000 To 25K With AC💚😋💚😋Kolkata Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Kolkata Escort Service Call Girls, ₹5000 To 25K With AC💚😋Sheetaleventcompany
 
VIP Kolkata Call Girl New Town 👉 8250192130 Available With Room
VIP Kolkata Call Girl New Town 👉 8250192130  Available With RoomVIP Kolkata Call Girl New Town 👉 8250192130  Available With Room
VIP Kolkata Call Girl New Town 👉 8250192130 Available With Roomdivyansh0kumar0
 
Vip sexy Call Girls Service In Sector 137,9999965857 Young Female Escorts Ser...
Vip sexy Call Girls Service In Sector 137,9999965857 Young Female Escorts Ser...Vip sexy Call Girls Service In Sector 137,9999965857 Young Female Escorts Ser...
Vip sexy Call Girls Service In Sector 137,9999965857 Young Female Escorts Ser...Call Girls Noida
 
No Advance 9053900678 Chandigarh Call Girls , Indian Call Girls For Full Ni...
No Advance 9053900678 Chandigarh  Call Girls , Indian Call Girls  For Full Ni...No Advance 9053900678 Chandigarh  Call Girls , Indian Call Girls  For Full Ni...
No Advance 9053900678 Chandigarh Call Girls , Indian Call Girls For Full Ni...Vip call girls In Chandigarh
 
Jalandhar Female Call Girls Contact Number 9053900678 💚Jalandhar Female Call...
Jalandhar  Female Call Girls Contact Number 9053900678 💚Jalandhar Female Call...Jalandhar  Female Call Girls Contact Number 9053900678 💚Jalandhar Female Call...
Jalandhar Female Call Girls Contact Number 9053900678 💚Jalandhar Female Call...Call Girls Service Chandigarh Ayushi
 
Call Now ☎ 9999965857 !! Call Girls in Hauz Khas Escort Service Delhi N.C.R.
Call Now ☎ 9999965857 !! Call Girls in Hauz Khas Escort Service Delhi N.C.R.Call Now ☎ 9999965857 !! Call Girls in Hauz Khas Escort Service Delhi N.C.R.
Call Now ☎ 9999965857 !! Call Girls in Hauz Khas Escort Service Delhi N.C.R.ktanvi103
 

Recently uploaded (20)

VIP Call Girls Noida Jhanvi 9711199171 Best VIP Call Girls Near Me
VIP Call Girls Noida Jhanvi 9711199171 Best VIP Call Girls Near MeVIP Call Girls Noida Jhanvi 9711199171 Best VIP Call Girls Near Me
VIP Call Girls Noida Jhanvi 9711199171 Best VIP Call Girls Near Me
 
Call Girls Service Chandigarh Gori WhatsApp ❤7710465962 VIP Call Girls Chandi...
Call Girls Service Chandigarh Gori WhatsApp ❤7710465962 VIP Call Girls Chandi...Call Girls Service Chandigarh Gori WhatsApp ❤7710465962 VIP Call Girls Chandi...
Call Girls Service Chandigarh Gori WhatsApp ❤7710465962 VIP Call Girls Chandi...
 
Call Girls in Mohali Surbhi ❤️🍑 9907093804 👄🫦 Independent Escort Service Mohali
Call Girls in Mohali Surbhi ❤️🍑 9907093804 👄🫦 Independent Escort Service MohaliCall Girls in Mohali Surbhi ❤️🍑 9907093804 👄🫦 Independent Escort Service Mohali
Call Girls in Mohali Surbhi ❤️🍑 9907093804 👄🫦 Independent Escort Service Mohali
 
Call Girls Service Chandigarh Grishma ❤️🍑 9907093804 👄🫦 Independent Escort Se...
Call Girls Service Chandigarh Grishma ❤️🍑 9907093804 👄🫦 Independent Escort Se...Call Girls Service Chandigarh Grishma ❤️🍑 9907093804 👄🫦 Independent Escort Se...
Call Girls Service Chandigarh Grishma ❤️🍑 9907093804 👄🫦 Independent Escort Se...
 
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service Available
 
Russian Escorts Aishbagh Road * 9548273370 Naughty Call Girls Service in Lucknow
Russian Escorts Aishbagh Road * 9548273370 Naughty Call Girls Service in LucknowRussian Escorts Aishbagh Road * 9548273370 Naughty Call Girls Service in Lucknow
Russian Escorts Aishbagh Road * 9548273370 Naughty Call Girls Service in Lucknow
 
Model Call Girl in Subhash Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Subhash Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Subhash Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Subhash Nagar Delhi reach out to us at 🔝9953056974🔝
 
pOOJA sexy Call Girls In Sector 49,9999965857 Young Female Escorts Service In...
pOOJA sexy Call Girls In Sector 49,9999965857 Young Female Escorts Service In...pOOJA sexy Call Girls In Sector 49,9999965857 Young Female Escorts Service In...
pOOJA sexy Call Girls In Sector 49,9999965857 Young Female Escorts Service In...
 
Leading transformational change: inner and outer skills
Leading transformational change: inner and outer skillsLeading transformational change: inner and outer skills
Leading transformational change: inner and outer skills
 
College Call Girls Dehradun Kavya 🔝 7001305949 🔝 📍 Independent Escort Service...
College Call Girls Dehradun Kavya 🔝 7001305949 🔝 📍 Independent Escort Service...College Call Girls Dehradun Kavya 🔝 7001305949 🔝 📍 Independent Escort Service...
College Call Girls Dehradun Kavya 🔝 7001305949 🔝 📍 Independent Escort Service...
 
Udaipur Call Girls 📲 9999965857 Call Girl in Udaipur
Udaipur Call Girls 📲 9999965857 Call Girl in UdaipurUdaipur Call Girls 📲 9999965857 Call Girl in Udaipur
Udaipur Call Girls 📲 9999965857 Call Girl in Udaipur
 
VIP Call Girl Sector 88 Gurgaon Delhi Just Call Me 9899900591
VIP Call Girl Sector 88 Gurgaon Delhi Just Call Me 9899900591VIP Call Girl Sector 88 Gurgaon Delhi Just Call Me 9899900591
VIP Call Girl Sector 88 Gurgaon Delhi Just Call Me 9899900591
 
Call Girl Dehradun Aashi 🔝 7001305949 🔝 💃 Independent Escort Service Dehradun
Call Girl Dehradun Aashi 🔝 7001305949 🔝 💃 Independent Escort Service DehradunCall Girl Dehradun Aashi 🔝 7001305949 🔝 💃 Independent Escort Service Dehradun
Call Girl Dehradun Aashi 🔝 7001305949 🔝 💃 Independent Escort Service Dehradun
 
#9711199012# African Student Escorts in Delhi 😘 Call Girls Delhi
#9711199012# African Student Escorts in Delhi 😘 Call Girls Delhi#9711199012# African Student Escorts in Delhi 😘 Call Girls Delhi
#9711199012# African Student Escorts in Delhi 😘 Call Girls Delhi
 
💚😋Kolkata Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Kolkata Escort Service Call Girls, ₹5000 To 25K With AC💚😋💚😋Kolkata Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Kolkata Escort Service Call Girls, ₹5000 To 25K With AC💚😋
 
VIP Kolkata Call Girl New Town 👉 8250192130 Available With Room
VIP Kolkata Call Girl New Town 👉 8250192130  Available With RoomVIP Kolkata Call Girl New Town 👉 8250192130  Available With Room
VIP Kolkata Call Girl New Town 👉 8250192130 Available With Room
 
Vip sexy Call Girls Service In Sector 137,9999965857 Young Female Escorts Ser...
Vip sexy Call Girls Service In Sector 137,9999965857 Young Female Escorts Ser...Vip sexy Call Girls Service In Sector 137,9999965857 Young Female Escorts Ser...
Vip sexy Call Girls Service In Sector 137,9999965857 Young Female Escorts Ser...
 
No Advance 9053900678 Chandigarh Call Girls , Indian Call Girls For Full Ni...
No Advance 9053900678 Chandigarh  Call Girls , Indian Call Girls  For Full Ni...No Advance 9053900678 Chandigarh  Call Girls , Indian Call Girls  For Full Ni...
No Advance 9053900678 Chandigarh Call Girls , Indian Call Girls For Full Ni...
 
Jalandhar Female Call Girls Contact Number 9053900678 💚Jalandhar Female Call...
Jalandhar  Female Call Girls Contact Number 9053900678 💚Jalandhar Female Call...Jalandhar  Female Call Girls Contact Number 9053900678 💚Jalandhar Female Call...
Jalandhar Female Call Girls Contact Number 9053900678 💚Jalandhar Female Call...
 
Call Now ☎ 9999965857 !! Call Girls in Hauz Khas Escort Service Delhi N.C.R.
Call Now ☎ 9999965857 !! Call Girls in Hauz Khas Escort Service Delhi N.C.R.Call Now ☎ 9999965857 !! Call Girls in Hauz Khas Escort Service Delhi N.C.R.
Call Now ☎ 9999965857 !! Call Girls in Hauz Khas Escort Service Delhi N.C.R.
 

2022-05-31 ISN Webinar DSA negative ABMR .pptx

  • 1. Microvascular rejection in the absence of anti-HLA DSAs Maarten Naesens, MD PhD KU Leuven, Belgium ISN webinar May 31st 2022
  • 2. 1991 1993 1995 1997 1999 2001 2003 2005 2007 2009 2011 2013 2015 2017 2019 2022 1. Tissue injury 2. Antibody interaction 3. Serological evidence Microvascular inflammation Microvascular inflammation C4d deposition C4d deposition HLA-DSA
  • 3. Not considered as sABMR or ABMR in any Banff update n=3171 Banff’01 Banff’13 Banff’17 DSA+ C4d- MVI+ DSA- C4d- MVI+ DSA+/C4d+ v > 0 ABMR n=199 sABMR n=292 ABMR n=237 No ABMR n=254 DSA- C4d+ 1st/MVI+ DSA- C4d- MVI+ DSA+ C4d- 1st+ Isolated ptc Callemeyn, al. Am J Transplant 2021. ABMR n=74 sABMR n=238 No ABMR n=179
  • 4. N=935 No ABMRh (N=727; 78%) ABMRh (N=208; 22%) HLA-DSA positive ABMRh (N=85; 41%) HLA-DSA negative ABMRh N=123 (59%) We observed a very high percentage of patients with ABMRh without HLA-DSA Senev et al. Am J Transplant 2019  .  .  Ba
  • 5. Coemans et al. Transplant Int 2021 Absolute number of cases B. Histological picture of antibody-mediated rejection D. Transplant glomerulopathy N = 1000 transplants; 3594 posttransplant biopsies There is a high number of cases with ABMR histology without HLA-DSA
  • 6. DSAneg ABMRh differs from DSApos ABMRh (97% MVI) HISTOLOGICAL PICTURE OF ABMR (Banff criteria 1 and 2) N=208 patients HLA-DSA positive N=85 HLA-DSA negative N=123 More graft failure (33%) Less graft failure (15%) Time after transplantation (< 1y) Light microscopic appearance More Repeated (52%) More transient (27% repeat) More C4d positivity (55%) Less C4d positivity (38%) C4d p<0.001 p<0.001 p<0.01 First clinical presentation Equal Senev et al. Am J Transplant 2019
  • 7. DSAnegABMRh DSAposABMRh Senev et al. Am J Transplant 2018 Outcome of HLA-DSA negative ABMRh is better than in HLA-DSA positive ABMRh
  • 8. Outcome of HLA-DSA negative ABMRh is better than in HLA-DSA positive ABMRh Bestard & Grinyo, Am J Transplant 2018 Koenig et al Nat Comm 2019
  • 9. ABMRh -> transplant glomerulopathy: one entity! Logit (ABMR) Time post-transplant First occurrence cg • Highly significant in entire cohort (HR 1.19, p<0.001) • And even in the DSA negative group (HR 1.16, p<0.001)  ABMRh/cg ‘Exposure to’ ABMRh Joint modeling Coemans et al. Transplant Int., 2021
  • 10. Association between time-dependent aABMRh, cg and aABMRh/cg and death-censored graft failure (N=837 HLA-DSA negative patients; 3140 biopsies) Coemans et al. Transplant Int., 2021 Parameters in the survival sub-modela # phenotype occurrences HR (95% CI) P-value aABMRh 205 1.17 (0.97 – 1.43) 0.10 cg 79 1.25 (1.08 – 1.55) 0.004 aABMRh/cg 268 1.32 (1.07 – 1.61) 0.008
  • 11. Halloran et al. Am J Transplant, May 2022 Association between molecular ABMR and death-censored graft failure is independent of the HLA-DSA status (N=268) Callemeyn et al. J Am Soc Nephrol 2020 (N=224)
  • 12. Callemeyn et al. Kidney Int 2022 The cellular infiltrates of kidney transplant rejection HLA antigen mismatch “Missing Self”
  • 13. NK cells are kept in balance by inhibitory and activating receptors KIR
  • 14. Tumoral NK cells activate by “absence of self” (missing self)
  • 15. NK cells activate by “absence of self” (missing self)
  • 16. The concept of missing self requires NK cell education Callemeyn et al. J Am Soc Nephrol 2021
  • 17. Missing self, direct NK cell activation and MicroVascular Inflammation Koenig et al. Nature Commun 2019 A B C
  • 18. Missing self associates with microvascular inflammation (MVI) “high” missing self Callemeyn et al. J Am Soc Nephrol 2021
  • 19. Missing self independently increases risk of MVI Pretransplant HLA-DSA Callemeyn et al. J Am Soc Nephrol 2021 Koenig et al. J Am Soc Nephrol 2021
  • 20. Callemeyn et al. JASN 2021 Koenig et al. Nat Commun 2020 102/222 of MVI (46%) not yet explained 15/44 of MVI (34%) not yet explained Not all MVI is explained by DSA or by missing self
  • 21. There are many pathways of NK cell activation Hamada et al. HLA 2021
  • 22. Non-HLA Ab detection immunoassay (NHADIA) to detect non-HLA DSA Lamarthée et al JASN 2021
  • 23. MICA is confirmed as minor histocompatilibty antigen in kidney transplantation leading to anti-MICA DSA and microvascular rejection Carapito et al Nat Med 2022
  • 24. N=935 No ABMRh (N=727; 78%) ABMRh (N=208; 22%) HLA-DSA positive ABMRh (N=85; 41%) HLA-DSA negative ABMRh N=123 (59%) CONCLUSION: DSA-negative Microvascular Rejection is common and further research is needed Senev et al. Am J Transplant 2019
  • 25. Not considered as sABMR or ABMR in any Banff update n=3171 Banff’01 Banff’13 Banff’17 DSA+ C4d- MVI+ DSA- C4d- MVI+ DSA+/C4d+ v > 0 ABMR n=199 sABMR n=292 ABMR n=74 sABMR n=238 No ABMR n=179 ABMR n=237 No ABMR n=254 DSA- C4d+ 1st/MVI+ DSA- C4d- MVI+ DSA+ C4d- 1st+ Isolated ptc Callemeyn, al. Am J Transplant 2021. ABMR (HLA-DSApos) MVR (HLA-DSAneg) (MVI based on restricted definition) No ABMR (DSA+) New proposal

Editor's Notes

  1. 15 minutes
  2. Theoretically, a similar situation can arise in organ transplantation. If the organ that is transplanted has a different MHC class I repertoire than the recipient. This could lead to disinhibition of the NK cells, which get activated and degranulate cytotoxic molecules ultimately killing the target donor cells, thus damaging the transplanted organ.